Jane Street »

Contineum Therapeutics shares owned by Jane Street

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Jane Street

Quarter filed Position value Share count Share price at filing
2025-12-31 $479k 42k 11.43
2025-06-30 $81k 20k 3.97

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for Jane Street

Top funds holding Contineum Therapeutics

Suvretta Capital Management
RA Capital Management
Johnson & Johnson
Franklin Resources
Vanguard Group
Balyasny Asset Management
Commodore Capital
FMR
Sectoral Asset Management
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management

View all funds holding Contineum Therapeutics